AlphAIalphai — Financial news for AI agents
stocktitan.netSEP 41 min read$CBRS

After selling 300K+ shares, Cerebras (CBRS) insider lines up another stock sale

Cerebras Systems (CBRS) insider Andrew Feldman filed a notice to sell 37,441 shares via option exercise on Sept. 4, 2026, with Morgan Stanley as broker. He and related parties sold over 300,000 shares in the past three months, some under a 10b5-1 plan.

Original reporting
stocktitan.net
Published Sep 4, 2026, 8:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 5, 2026, 4:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$CBRS
Bearish
medium confidence
Mentioned
$CBRS
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CBRSBearishLow
01

Why it matters

The filing provides the first public notice of the sale, offering traders a data point for short-term positioning.

02

Market read

First report of a notable insider sale for CBRS; modest impact expected.

03

What to watch

Potential upcoming product announcements could offset sell pressure.

Relevance 4/10Novelty 4/10Timing: Sept 4 2026 filing date

Background

Form 144 filings are public disclosures of planned insider sales under Rule 144, often used to gauge insider sentiment.

Company-level read

Ticker impact

$CBRSBearishMedium confidence
Context

Cerebras insider Andrew Feldman filed a Form 144 to sell 37,441 shares on Sept. 4, 2026 after exercising options and disclosed prior sales of over 300,000 shares.

Expected impact

Short-term downward pressure as market absorbs insider sell volume.

Evidence & confidence

The filing reveals a sizable insider sell, but the amount is modest relative to market cap and does not indicate a strategic shift.

Market effects

Sector

May signal insider confidence concerns for AI hardware sector.

Regional

Limited to US-listed AI chip makers.

Global

Low global impact.

Counterpoint

What could challenge this read

Insider may be diversifying; sell does not necessarily reflect company outlook.

Key entities

  • Insider
    Andrew Feldman

    Cerebras Systems Inc. founder and CEO, filing the stock sale.

Read at source← All news

Related articles

SEP 6
$CBRSMedAI 8/10

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.

fool.com3 min
SEP 4
$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.

stocktwits.com2 min
SEP 4
$CBRSMed

CBRS Stock Slides As Cerebras Ramps AI Capacity And Growth

Cerebras Systems Inc. (CBRS) stock rose 10.73% on September 4, 2026, driven by investor optimism around AI chip adoption. The company reported Q2 2026 revenue of $510M and a loss of $451M, with a high price-to-sales multiple of 117x. Morgan Stanley reiterated its overweight rating, citing strong AI demand and partnerships. CBRS faces execution risks due to high spending on AI capacity expansion.

stockstotrade.com4 min
SEP 4
$CBRSMed

Cerebras Systems Stock Slides As Wall Street Backs Aggressive AI Expansion

Cerebras Systems Inc. (CBRS) stock rose 10.91% on September 4, 2026, driven by bullish sentiment around its AI chip advancements. The company reported quarterly revenue of $180.1M and a net loss of $450.5M, with a price-to-sales ratio of 117.36. Morgan Stanley reiterated its overweight rating, citing surging AI inference demand and expected revenue growth. However, risks include execution challenges in data center expansion and profitability concerns.

timothysykes.com3 min
SEP 4
$CBRSMed

Cerebras Stock Jumps 12% as Finland Capacity Tests a $51 Billion Valuation

Cerebras Systems (CBRS) shares rose 12% to $213.26, nearing a $51B valuation. The surge followed a Finland data-center contract announcement, with plans for 50MW, 80MW, and 165MW stages. The stock initially fell 6.3% on the news but recovered. Cerebras has $8.6B in cash and $25.4B in performance obligations, with a 2026 revenue forecast of $880M-$890M.

ts2.tech2 min
SEP 4
$CBRSHighAI 8/10

Why is Cerebras Systems stock surging today?

Cerebras Systems stock rose 6.4% to $202.61 after announcing a 165 MW AI data center in Finland, partnering with Compute Nordic Finland. The company reported Q2 2026 revenue of $209.9M, beating estimates, and raised full-year guidance to $880M-$890M. Analysts and ARK Invest have shown support.

investing.com2 min